Abstract:Objective Previous studies suggested that high mtDNA levels may be used for identification of euploid embryos with poor developmental competence. This does agree with the other observations on the relationship of high mtDNA levels to poor implantation potential, observable in embryos at the cleavage and blastocyst stage, despite using different approaches in estimating the mtDNA levels, suggesting a possibility of some underlying errors in the measurements of mtDNA copy number in different studies. We present here the data of a blinded retrospective analysis of the reproductive outcomes of euploid embryo transfers, depending on mtDNA levels, performed by identical methodology in two different groups of patients in two different clinics. Materials and Methods Two independent PGT clinics performed this retrospective re-analysis of mtDNA levels following single blastocyst transfers (group A, n=49; group B, n=70) or double blastocyst transfers (group A, n=36; group B n=29). The mtDNA levels were correlated with implantation, miscarriage and live-birth. Aneuploidy testing was performed by NGS and the data was used to calculate the mtDNA/gDNA ratio (mtDNA ratio), expressed as the number of mapped mtDNA sequencing reads x 100%/ number of mapped autosomal sequencing reads. Results Only embryos identified as euploid and suitable for transfer were analyzed. Implantation rates for single embryo transfers were 43% (group A) and 55% (group B) and for double embryo transfers 54% (group A) and 62% (group B). Overall, the average mtDNA ratio was 0.018% with a range of 0.002% to 0.14%. For the single embryo transfer groups, there was no significant difference for the average mtDNA ratio, or the mtDNA ratio profile of the pregnant and non-pregnant women. Amongst both pregnant groups, there was no obvious correlation of mtDNA ratios with the miscarriage subgroup and those with a continuing, successful pregnancy. Further, there was no obvious trend between the mtDNA ratio and twin delivery, singleton delivery, miscarriage or failure to implant. Conclusions The study could not support the findings suggesting that highmtDNA ratios are an indicator of implantation failure. The results show that the mtDNA ratio of trophectoderm biopsy samples cannot be used as an additional parameter for pre-selection of euploid embryos for transfer. Previous studies suggested that high mtDNA levels may be used for identification of euploid embryos with poor developmental competence. This does agree with the other observations on the relationship of high mtDNA levels to poor implantation potential, observable in embryos at the cleavage and blastocyst stage, despite using different approaches in estimating the mtDNA levels, suggesting a possibility of some underlying errors in the measurements of mtDNA copy number in different studies. We present here the data of a blinded retrospective analysis of the reproductive outcomes of euploid embryo transfers, depending on mtDNA levels, performed by identical methodology in two different groups of patients in two different clinics. Two independent PGT clinics performed this retrospective re-analysis of mtDNA levels following single blastocyst transfers (group A, n=49; group B, n=70) or double blastocyst transfers (group A, n=36; group B n=29). The mtDNA levels were correlated with implantation, miscarriage and live-birth. Aneuploidy testing was performed by NGS and the data was used to calculate the mtDNA/gDNA ratio (mtDNA ratio), expressed as the number of mapped mtDNA sequencing reads x 100%/ number of mapped autosomal sequencing reads. Only embryos identified as euploid and suitable for transfer were analyzed. Implantation rates for single embryo transfers were 43% (group A) and 55% (group B) and for double embryo transfers 54% (group A) and 62% (group B). Overall, the average mtDNA ratio was 0.018% with a range of 0.002% to 0.14%. For the single embryo transfer groups, there was no significant difference for the average mtDNA ratio, or the mtDNA ratio profile of the pregnant and non-pregnant women. Amongst both pregnant groups, there was no obvious correlation of mtDNA ratios with the miscarriage subgroup and those with a continuing, successful pregnancy. Further, there was no obvious trend between the mtDNA ratio and twin delivery, singleton delivery, miscarriage or failure to implant. The study could not support the findings suggesting that highmtDNA ratios are an indicator of implantation failure. The results show that the mtDNA ratio of trophectoderm biopsy samples cannot be used as an additional parameter for pre-selection of euploid embryos for transfer.

Digital PCR Detection of Mtdna/gdna Ratio in Embryo Culture Medium for Prediction of Embryo Development Potential

The Mitochondrial DNA Content Can Not Predict the Embryo Viability

Mitochondrial DNA Content May Not Be a Reliable Screening Biomarker for Live Birth After Single Euploid Blastocyst Transfer

Mitochondrial DNA Levels are not a simple indicator for preselection of Euploid Embrios with higher developmental potential

Non-invasive Metabolomic Profiling of Embryo Culture Medium Using Raman Spectroscopy with Deep Learning Model Predicts the Blastocyst Development Potential of Embryos

Non-invasive pre-implantation aneuploidy screening and diagnosis of beta thalassemia IVSII654 mutation using spent embryo culture medium

[Analysis of related factors influencing the detection rate of mosaic embryo and the pregnancy outcomes with mosaic embryo transfers]

Prediction model for day 3 embryo implantation potential based on metabolites in spent embryo culture medium

Noninvasive Metabolomic Profiling Of Human Embryo Culture Media Using A Simple Spectroscopy Adjunct To Morphology For Embryo Assessment In In Vitro Fertilization (Ivf)

MicroRNAs secreted by human embryos could be potential biomarkers for clinical outcomes of assisted reproductive technology

Investigating developmental characteristics of biopsied blastocysts stratified by mitochondrial copy numbers using time-lapse monitoring

Embryo selection through non-invasive preimplantation genetic testing with cell-free DNA in spent culture media: a protocol for a multicentre, double-blind, randomised controlled trial

Trophectoderm Mitochondrial DNA Content Associated with Embryo Quality and Day-5 Euploid Blastocyst Transfer Outcomes

Concordance of PGT for aneuploidies between blastocyst biopsies and spent blastocyst culture medium

#278 : Relationship Between Level Expression of miRNA-191 and miRNA-548c-3p in Embryo Culture Medium and Embryo Chromosomal Status

Quantitative Proteomics and Metabolomics of Culture Medium from Single Human Embryo Reveal Embryo Quality-Related Multiomics Biomarkers

Comparison of the developmental potential of the morphological good embryos between normal-responders with low and high rate of MG day 3 embryos formation

Development of a Novel Non-invasive Metabolomics Assay to Predict Implantation Potential of Human Embryos

34. RETROSPECTIVE PGT-A ANALYSIS FOR MULTIPLE DISPLACEMENT AMPLIFICATION PRODUCTS OF EMBRYOS CORRESPONDING TO 104 LIVE BIRTHS BY NEXT-GENERATION SEQUENCING (NGS)

Presence of embryonic DNA in culture medium

Non-invasive Embryo Selection Strategy for Clinical IVF to Avoid Wastage of Potentially Competent Embryos